[1] 龚晓霖,储怡星,范基农,等.真菌感染及其药敏试验方法[J] .检验医学,2005,20(1):81-83.
[2] Pfaller MA, Messer SA, Boyken L, et al. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002[J] . J Clin Microbiol, 2004, 42(7):3142-3146.
[3] 郑 冰,姚冬婷,应春妹,等. 医院感染光滑念珠菌耐药性及流行病学分析[J] . 检验医学,2012,27(6):461-466.
[4] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method[J] . Methods, 2001,25(4):402-408.
[5] Lockhart SR, Joly S, Pujol C, et al. Development and verification of fingerprinting probes for Candida glabrata[J] . Microbiology, 1997,14(Pt 12): 3733-3746.
[6] Borst A, Raimer MT, Warnock DW, et al. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole[J] . Antimicrob Agents Chemother, 2005,49(2):783-787.
[7] Niimi M, Nagai Y, Niimi K, et al. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole[J] . J Chromatogr B Analyt Technol Biomed Life Sci, 2002, 782(1-2):245-252.
[8] Sanglard D, Ischer F, Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata[J] . Antimicrob Agents Chemother,2001, 45(4):1174-1183.